明達醫(6527)股票可以買嗎?K線圖AI分析回答目標合理價
K線圖與股價本日交易資訊
資料日期: ,每天14:00後更新。
| 開 | 高 | 低 | 收 |
|---|---|---|---|
| 80.2 | 80.5 | 80.2 | 80.2 |
查看每日股價資訊表格
| 日期 | 開盤價 | 最高價 | 最低價 | 收盤價 | 成交量 |
|---|---|---|---|---|---|
| 2025/05/28 | 84.7 | 84.7 | 84 | 84.3 | 39 |
| 2025/05/29 | 83.4 | 84.4 | 83.4 | 83.8 | 8 |
| 2025/06/02 | 83.5 | 83.5 | 83 | 83.5 | 14 |
| 2025/06/03 | 84 | 84 | 83.5 | 84 | 17 |
| 2025/06/04 | 84 | 84.2 | 84 | 84.2 | 17 |
| 2025/06/05 | 84.2 | 84.2 | 84.2 | 84.2 | 6 |
| 2025/06/06 | 84.4 | 84.6 | 84.2 | 84.6 | 18 |
| 2025/06/09 | 91.3 | 93 | 90.7 | 91.6 | 3,329 |
| 2025/06/10 | 89 | 90 | 86.3 | 88.2 | 284 |
| 2025/06/11 | 88.2 | 89.9 | 87.3 | 87.3 | 71 |
| 2025/06/12 | 88.8 | 88.8 | 86.8 | 88.5 | 110 |
| 2025/06/13 | 88.8 | 88.8 | 87.4 | 88.5 | 29 |
| 2025/06/16 | 88.5 | 89.6 | 87.6 | 87.7 | 80 |
| 2025/06/17 | 86.6 | 87.7 | 86 | 86.5 | 25 |
| 2025/06/18 | 86.5 | 86.8 | 86.5 | 86.8 | 22 |
| 2025/06/19 | 88 | 88.3 | 87.8 | 88.3 | 61 |
| 2025/06/23 | 87.9 | 88.7 | 87.9 | 88.7 | 42 |
| 2025/06/24 | 89.3 | 89.3 | 87.3 | 88.8 | 79 |
| 2025/06/25 | 88.7 | 88.7 | 88.2 | 88.6 | 13 |
| 2025/06/26 | 87.8 | 87.8 | 87 | 87.1 | 36 |
| 2025/06/27 | 87.1 | 87.3 | 87 | 87.3 | 13 |
| 2025/06/30 | 87.8 | 87.8 | 86 | 87 | 129 |
| 2025/07/01 | 87.3 | 87.3 | 86.5 | 87 | 19 |
| 2025/07/02 | 87 | 87 | 87 | 87 | 7 |
| 2025/07/03 | 87.9 | 87.9 | 86.7 | 86.7 | 24 |
| 2025/07/04 | 86.3 | 86.7 | 85.8 | 86.7 | 80 |
| 2025/07/07 | 86 | 86 | 85.6 | 85.6 | 8 |
| 2025/07/08 | 85.1 | 85.7 | 85 | 85.2 | 13 |
| 2025/07/09 | 81.9 | 85.5 | 81.9 | 85.5 | 32 |
| 2025/07/10 | 86 | 87 | 86 | 87 | 32 |
| 2025/07/11 | 87.8 | 87.8 | 87 | 87 | 3 |
| 2025/07/14 | 87 | 87 | 87 | 87 | 43 |
| 2025/07/15 | 86 | 87 | 85.9 | 87 | 56 |
| 2025/07/16 | 86.1 | 86.6 | 86.1 | 86.3 | 7 |
| 2025/07/17 | 86.3 | 86.3 | 85.8 | 85.8 | 78 |
| 2025/07/18 | 86.3 | 86.7 | 86 | 86.7 | 30 |
| 2025/07/21 | 86.5 | 86.5 | 86 | 86.5 | 15 |
| 2025/07/22 | 86.7 | 86.7 | 85.9 | 86.5 | 25 |
| 2025/07/23 | 86.5 | 88.6 | 86.5 | 88.6 | 64 |
| 2025/07/24 | 86.9 | 87.5 | 86.9 | 87.2 | 35 |
| 2025/07/25 | 87.5 | 87.6 | 87.2 | 87.3 | 25 |
| 2025/07/28 | 87 | 87.3 | 87 | 87.1 | 50 |
| 2025/07/29 | 87 | 87 | 86.5 | 87 | 38 |
| 2025/07/30 | 87 | 87 | 84.8 | 86.9 | 9 |
| 2025/07/31 | 85.3 | 85.3 | 85.3 | 85.3 | 5 |
| 2025/08/01 | 85 | 85.9 | 85 | 85.9 | 17 |
| 2025/08/04 | 86.3 | 86.3 | 85.5 | 85.6 | 9 |
| 2025/08/05 | 86.8 | 87.2 | 86 | 86.1 | 38 |
| 2025/08/06 | 86.1 | 87 | 86.1 | 86.4 | 38 |
| 2025/08/07 | 88 | 88 | 86.4 | 86.9 | 41 |
| 2025/08/08 | 86.3 | 86.9 | 86.1 | 86.9 | 26 |
| 2025/08/11 | 85.8 | 85.8 | 84.1 | 84.9 | 173 |
| 2025/08/12 | 84.9 | 86.4 | 84.8 | 86 | 24 |
| 2025/08/13 | 86 | 87 | 86 | 86 | 30 |
| 2025/08/14 | 87 | 87.2 | 86.5 | 87.2 | 35 |
| 2025/08/15 | 87 | 87.2 | 86.5 | 87.1 | 23 |
| 2025/08/18 | 87 | 87.5 | 87 | 87.5 | 169 |
| 2025/08/19 | 87.2 | 87.2 | 86.6 | 86.7 | 23 |
| 2025/08/20 | 86.5 | 86.5 | 86.3 | 86.4 | 11 |
| 2025/08/21 | 86.4 | 87.1 | 86.4 | 87.1 | 16 |
| 2025/08/22 | 86.6 | 87 | 86.6 | 86.9 | 25 |
| 2025/08/25 | 87.1 | 87.1 | 85 | 86 | 54 |
| 2025/08/26 | 86 | 86 | 86 | 86 | 21 |
| 2025/08/27 | 86.1 | 87.5 | 86 | 87.5 | 69 |
| 2025/08/28 | 87.4 | 87.5 | 87 | 87 | 35 |
| 2025/08/29 | 87 | 87.1 | 86.4 | 86.4 | 48 |
| 2025/09/01 | 87 | 87 | 86.6 | 87 | 42 |
| 2025/09/02 | 86.7 | 88 | 86.7 | 88 | 81 |
| 2025/09/03 | 88 | 88.2 | 88 | 88 | 29 |
| 2025/09/04 | 87.7 | 90.8 | 87.1 | 88.8 | 42 |
| 2025/09/05 | 88.5 | 89.4 | 88.5 | 88.6 | 29 |
| 2025/09/08 | 88.7 | 88.8 | 87.6 | 87.9 | 35 |
| 2025/09/09 | 87.6 | 88 | 86.9 | 88 | 19 |
| 2025/09/10 | 87.8 | 88.2 | 87.1 | 87.1 | 205 |
| 2025/09/11 | 87 | 87 | 86.6 | 86.6 | 12 |
| 2025/09/12 | 86.5 | 86.5 | 86 | 86.5 | 21 |
| 2025/09/15 | 86.2 | 86.2 | 86.1 | 86.1 | 7 |
| 2025/09/16 | 87.5 | 87.5 | 86 | 86 | 19 |
| 2025/09/17 | 85 | 86.1 | 85 | 86 | 107 |
| 2025/09/18 | 86 | 86.1 | 85.5 | 85.6 | 77 |
| 2025/09/19 | 85.8 | 86.5 | 85.8 | 86.5 | 13 |
| 2025/09/22 | 86.1 | 86.3 | 86 | 86.1 | 24 |
| 2025/09/23 | 85.6 | 86 | 85.3 | 86 | 8 |
| 2025/09/25 | 85.7 | 87.3 | 85.7 | 87.3 | 37 |
| 2025/09/26 | 86.3 | 86.4 | 86.1 | 86.1 | 8 |
| 2025/09/30 | 86 | 86 | 85.8 | 85.8 | 18 |
| 2025/10/01 | 85.3 | 85.5 | 85.3 | 85.5 | 5 |
| 2025/10/02 | 85.8 | 85.9 | 85.7 | 85.7 | 12 |
| 2025/10/03 | 85.3 | 86 | 85.3 | 86 | 15 |
| 2025/10/07 | 86 | 86 | 85.7 | 85.7 | 6 |
| 2025/10/08 | 85.2 | 86 | 85.2 | 86 | 25 |
| 2025/10/09 | 86 | 86.1 | 85.6 | 86.1 | 19 |
| 2025/10/13 | 85.2 | 86.1 | 84.6 | 85.2 | 16 |
| 2025/10/14 | 86.1 | 86.2 | 84.6 | 84.6 | 260 |
| 2025/10/15 | 84.6 | 85.1 | 84.6 | 85.1 | 40 |
| 2025/10/16 | 85 | 85 | 85 | 85 | 10 |
| 2025/10/17 | 83.8 | 84.3 | 83.5 | 83.9 | 261 |
| 2025/10/20 | 83.8 | 84 | 83.5 | 83.5 | 25 |
| 2025/10/21 | 83.5 | 83.5 | 83 | 83.5 | 167 |
| 2025/10/22 | 83.2 | 83.6 | 83.2 | 83.6 | 12 |
| 2025/10/23 | 83.2 | 83.6 | 83.2 | 83.2 | 20 |
| 2025/10/27 | 83.2 | 83.3 | 83 | 83.1 | 87 |
| 2025/10/28 | 83 | 83 | 82.6 | 82.6 | 11 |
| 2025/10/29 | 82.9 | 82.9 | 81.7 | 81.7 | 40 |
| 2025/10/30 | 81.8 | 81.8 | 80.8 | 80.9 | 126 |
| 2025/10/31 | 80.6 | 81.6 | 80 | 81.6 | 71 |
| 2025/11/03 | 79.1 | 81 | 79 | 81 | 40 |
| 2025/11/04 | 82 | 82.6 | 81.2 | 81.9 | 23 |
| 2025/11/05 | 81.1 | 82.3 | 81 | 82.3 | 18 |
| 2025/11/06 | 82 | 82.5 | 82 | 82 | 10 |
| 2025/11/07 | 81.5 | 82.7 | 81.5 | 82.7 | 14 |
| 2025/11/10 | 82.5 | 83.3 | 82.5 | 82.6 | 79 |
| 2025/11/11 | 82.6 | 82.6 | 82.5 | 82.5 | 20 |
| 2025/11/12 | 82.5 | 82.7 | 82.3 | 82.4 | 21 |
| 2025/11/13 | 81.9 | 81.9 | 81.8 | 81.9 | 18 |
| 2025/11/14 | 81.5 | 81.8 | 81 | 81.8 | 70 |
| 2025/11/17 | 82 | 82 | 81.5 | 81.5 | 12 |
| 2025/11/18 | 80.7 | 80.7 | 80.5 | 80.6 | 45 |
| 2025/11/19 | 80.6 | 80.6 | 80.2 | 80.2 | 36 |
| 2025/11/20 | 80.2 | 80.5 | 80.2 | 80.2 | 90 |
AI的K線圖分析和操作建議
以下內容由AI生成:
點擊查看。AI建議自動產生於:,輸入:市場模型。 明達醫 (6527) 近90日股價走勢分析 根據所提供的明…
明達醫 (6527) 近90日股價走勢分析
根據所提供的明達醫 (6527) 近90日K線圖,判斷未來數天至數週股價趨勢偏向於盤整後可能出現反彈,但上漲空間有限,需謹慎觀察。理由如下:
- 長期趨勢向下,但近期有止跌跡象:觀察過去90天的走勢,股價從高點約93元一路下跌至2025年10月底觸及低點約79元。然而,自11月初以來,股價開始出現反彈,並且在11月中旬(約11月10日附近)出現了一根帶有長下影線的綠色K線,顯示下方支撐力道增強。
- 短期均線糾纏,意圖翻揚:目前MA5(短期均線,綠色線)正逐漸向上穿越MA20(長期均線,橘色線),雖然尚未形成明確的金叉,但此現象通常預示著短期內股價有止跌回穩並嘗試反彈的意圖。
- 成交量變化:圖表中所示的成交量柱狀圖,在近期(11月)的走勢中,雖然沒有出現巨幅成交量的放大,但有幾根交易日出現了相對溫和的量能變化,這可能表示市場正在消化賣壓,並有部分買盤介入。
- 關鍵價位:目前股價約在82-83元之間,此價位為近期反彈的起點。若能守穩此價位,則有機會向 MA20(目前約在83.5元附近)及上方壓力區(約85-87元)進行挑戰。
綜合以上幾點,雖然股價從長期來看仍處於下降趨勢,但近期出現了止跌、均線有翻揚跡象,且成交量有溫和放大的潛力,因此預期短期內股價有機會展開一波反彈。然而,由於大趨勢仍然偏弱,且上方壓力區明顯,預計反彈的高度可能受限。
未來目標價格區間
基於上述分析,預期未來數天至數週,明達醫 (6527) 的股價可能落在以下區間:
- 樂觀情境:若能成功突破MA20並站穩,挑戰上方壓力區,則有機會觸及 85元至87元 的區間。
- 較為謹慎的預期:更為實際的預期是,股價將在 83元至85元 之間進行震盪整理,尋找上攻的動能。
因此,綜合判斷,未來目標價格區間可設定在 83元至87元。但若股價跌破82元,則需警惕繼續下行的風險。
操作建議
對於散戶投資人而言,面對「XX股票可以買嗎」的疑問,明達醫 (6527) 目前的狀況建議採取 謹慎觀望、逢低介入、設定停損 的操作策略。
- 「可以買嗎?」的解答:現階段不建議追高買進。若欲布局,則建議等待股價回測支撐(例如:82元附近)且出現止跌訊號時,小量分批介入。
- 買入時機:
- 尋找股價回測至 82 元附近,且出現看漲的K線型態(如:錘子線、早晨之星等)。
- 觀察成交量是否溫和放大,並伴隨股價的推升。
- 留意MA5是否持續位於MA20之上,並形成穩定的金叉。
- 停損設定:務必設定明確的停損點。例如,若股價跌破 81 元,則應毫不猶豫地執行停損,以避免更大的損失。
- 資金控管:對於散戶投資人,應嚴格控管單一股票的投資比例,切勿將所有資金投入。
- 風險警示:醫藥類股受到產業政策、研發進度、市場需求等多重因素影響,波動性較大。投資人應充分了解公司基本面,並自行承擔投資風險。
- 長期投資考量:若看好明達醫的長期發展,則可考慮以較長期的視角布局,但仍需在股價相對低位時分批買入,並做好風險控管。
總結而言,明達醫 (6527) 目前呈現築底反彈的初步跡象,預期未來數天至數週股價可能在 83元至87元區間震盪。散戶投資人若有意願買入,應採取逢低、分批、嚴設停損的操作策略,並謹慎評估風險。
股權分散表
查看每日股權分散表表格
| 日期 | 100張以下持股比例 | 100~1000張持股比例 | 1000張以上持股比例 | 總股東人數 |
|---|---|---|---|---|
| 2024/09/20 | 37.6% | 39.61% | 22.72% | 3,086 |
| 2024/09/27 | 37.68% | 43.02% | 19.22% | 3,036 |
| 2024/10/04 | 37.74% | 42.95% | 19.23% | 3,022 |
| 2024/10/11 | 37.25% | 43.35% | 19.34% | 3,006 |
| 2024/10/18 | 37.05% | 43.44% | 19.43% | 2,978 |
| 2024/10/25 | 36.84% | 43.57% | 19.52% | 2,960 |
| 2024/11/01 | 36.76% | 43.65% | 19.52% | 2,949 |
| 2024/11/08 | 36.71% | 43.66% | 19.56% | 2,932 |
| 2024/11/15 | 36.53% | 43.65% | 19.75% | 2,901 |
| 2024/11/22 | 36.42% | 43.65% | 19.85% | 2,886 |
| 2024/11/29 | 36.26% | 43.66% | 20.01% | 2,868 |
| 2024/12/06 | 36.26% | 43.67% | 20.01% | 2,861 |
| 2024/12/13 | 36.25% | 43.69% | 20.01% | 2,852 |
| 2024/12/20 | 36.18% | 43.75% | 20.01% | 2,844 |
| 2024/12/27 | 36.17% | 43.76% | 20.01% | 2,834 |
| 2025/01/03 | 36.16% | 43.76% | 20.01% | 2,832 |
| 2025/01/10 | 36.09% | 43.76% | 20.08% | 2,826 |
| 2025/01/17 | 35.94% | 43.78% | 20.2% | 2,823 |
| 2025/01/22 | 35.86% | 43.79% | 20.28% | 2,812 |
| 2025/02/07 | 35.88% | 43.78% | 20.28% | 2,808 |
| 2025/02/14 | 35.86% | 43.79% | 20.28% | 2,801 |
| 2025/02/21 | 35.5% | 44.14% | 20.28% | 2,885 |
| 2025/02/27 | 35.51% | 44.15% | 20.28% | 2,866 |
| 2025/03/07 | 35.38% | 44.15% | 20.39% | 2,858 |
| 2025/03/14 | 35.34% | 44.2% | 20.39% | 2,843 |
| 2025/03/21 | 35.34% | 44.21% | 20.39% | 2,844 |
| 2025/03/28 | 34.63% | 44.92% | 20.39% | 2,843 |
| 2025/04/02 | 34.56% | 44.98% | 20.39% | 2,826 |
| 2025/04/11 | 34.75% | 44.43% | 20.77% | 2,804 |
| 2025/04/18 | 34.98% | 44.07% | 20.86% | 2,787 |
| 2025/04/25 | 34.94% | 44.05% | 20.93% | 2,787 |
| 2025/05/02 | 34.91% | 44.05% | 20.93% | 2,775 |
| 2025/05/09 | 34.91% | 44.04% | 20.97% | 2,774 |
| 2025/05/16 | 34.84% | 44.04% | 21.04% | 2,762 |
| 2025/05/23 | 34.74% | 43.43% | 21.76% | 2,758 |
| 2025/05/29 | 34.95% | 42.96% | 22% | 2,747 |
| 2025/06/06 | 34.84% | 42.96% | 22.11% | 2,739 |
| 2025/06/13 | 35.33% | 42.46% | 22.14% | 2,747 |
| 2025/06/20 | 35.18% | 42.45% | 22.29% | 2,731 |
| 2025/06/27 | 35.02% | 42.43% | 22.48% | 2,714 |
| 2025/07/04 | 34.64% | 42.39% | 22.88% | 2,702 |
| 2025/07/11 | 34.61% | 42.37% | 22.97% | 2,684 |
| 2025/07/18 | 34.94% | 41.97% | 23.02% | 2,681 |
| 2025/07/25 | 34.47% | 41.96% | 23.5% | 2,661 |
| 2025/08/01 | 34.36% | 41.94% | 23.63% | 2,673 |
| 2025/08/08 | 33.95% | 42.33% | 23.63% | 2,661 |
| 2025/08/15 | 33.76% | 42.34% | 23.82% | 2,624 |
| 2025/08/22 | 33.57% | 42.32% | 24.05% | 2,611 |
| 2025/08/29 | 33.32% | 42.25% | 24.36% | 2,587 |
| 2025/09/05 | 33.24% | 42.2% | 24.49% | 2,582 |
| 2025/09/12 | 33.1% | 42.14% | 24.69% | 2,565 |
| 2025/09/19 | 33.03% | 41.75% | 25.14% | 2,565 |
| 2025/09/26 | 32.93% | 41.69% | 25.33% | 2,554 |
| 2025/10/03 | 32.92% | 41.67% | 25.33% | 2,544 |
| 2025/10/09 | 32.87% | 41.64% | 25.42% | 2,537 |
| 2025/10/17 | 32.8% | 41.58% | 25.54% | 2,517 |
| 2025/10/23 | 32.77% | 41.61% | 25.54% | 2,497 |
| 2025/10/31 | 32.18% | 42.22% | 25.54% | 2,489 |
| 2025/11/07 | 32.2% | 42.19% | 25.54% | 2,486 |
| 2025/11/14 | 32.34% | 42.06% | 25.54% | 2,486 |
目前尚無評論